GOSS 8-K 2026-11-10

Gossamer Bio, Inc. (GOSS) 8-K dated 2026-11-10 — accession 0001728117-26-000116.

Gossamer Bio, Inc. (GOSS) is a biotechnology company listed on US.

GOSS to acquire platform ($125M)

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.

Not investment advice. The GOSS SEC hub lists recent forms. The stock page is the research view.